Search

Zai Lab Ltd ADR

Atidarymo kaina

SektoriusSveikatos priežiūra

20.17 -1.71

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.06

Max

20.79

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-607K

-51M

Pardavimai

-28M

100M

Pelnas, tenkantis vienai akcijai

-0.46

Pelno marža

-51.215

Darbuotojai

1,784

EBITDA

4.1M

-44M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+58.05% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-67M

2.3B

Ankstesnė atidarymo kaina

21.88

Ankstesnė uždarymo kaina

20.17

Naujienos nuotaikos

By Acuity

47%

53%

134 / 340 reitingas Healthcare

Zai Lab Ltd ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-22 23:56; UTC

Correlated Moves
News

American Water Works Company Inc. is trading lower in after-market hours amid geopolitical tensions and rising crude oil prices impacting market sentiment.

2026-07-22 23:56; UTC

News

Wynn Resorts received approval to expand its Wynn Palace resort in Macau, including a new hotel and entertainment center. Shares showed little change in after-market trading.

2026-07-22 23:51; UTC

News

Rollins Inc shares fell after second-quarter results missed expectations. Adjusted EPS was $0.32, below the consensus estimate of $0.34, amid slowing growth.

2026-07-22 23:51; UTC

Social Media
News

CSX Corp reported second-quarter revenue of $3.94 billion and EPS of $0.54, exceeding expectations, leading to higher shares in after-market trading.

2026-07-22 23:51; UTC

Social Media
News

Joby Aviation will release its Q2 2026 results on August 5, generating positive investor sentiment. Shares are trading higher in after-market hours.

2026-07-22 23:51; UTC

Social Media
News

Southwest Airlines reported second-quarter earnings above estimates but missed on revenue, leading to shares trading lower in after-market hours.

2026-07-22 23:51; UTC

News

Norfolk Southern Corp shares are trading lower in after-market hours following Union Pacific and Canadian National Railway's agreement that may impact its competitive position.

2026-07-22 23:51; UTC

ETF Constituents
Social Media
News

Invesco QQQ Trust Series I is lower in after-market hours amid concerns over rising crude oil prices and geopolitical tensions affecting market sentiment.

2026-07-22 23:51; UTC

Social Media
Correlated Moves
News

Amazon.com Inc is under Senate investigation for alleged Chinese influence on its marketplace, contributing to a decline in investor sentiment and stock price after hours.

2026-07-22 23:51; UTC

ETF Constituents
News
Macro News

Vanguard Information Technology ETF is higher in after-market hours, driven by positive sentiment ahead of earnings from major tech firms and strong performances from key holdings.

2026-07-22 23:46; UTC

News

EQT Corporation's stock rose after it raised full-year natural gas production guidance and secured long-term supply agreements, despite lower-than-expected earnings.

2026-07-22 23:46; UTC

Social Media
News

Intel explores a partnership with SK Hynix for its Ohio facility. Shares are trading higher after securing Fortinet as its first external foundry customer.

2026-07-22 23:46; UTC

Social Media
News

Crown Castle reported second-quarter adjusted FFO of $1.13, exceeding estimates. Shares are higher in after-market trading following the results and strategic business sale.

2026-07-22 23:41; UTC

News

Goosehead Insurance shares rise in after-market hours following strong Q2 results, with revenue of $113.4 million and a leadership transition announcement.

2026-07-22 23:41; UTC

News

Community Health Systems reported a significant decline in net income and lowered its full-year EPS guidance, leading shares to trade lower in after-market hours.

2026-07-22 23:41; UTC

Social Media
News

Kinder Morgan's Q2 earnings of $0.37 per share exceeded estimates, driving shares higher in after-market trading. Revenue rose to $4.48 billion, surpassing expectations.

2026-07-22 23:36; UTC

Social Media
Correlated Moves
News

Shutterstock shares are lower in after-market hours following the suspension of dividends and the resignation of Chief Accounting Officer Steven Ciardiello.

2026-07-22 23:36; UTC

Correlated Moves
News

Microsoft shares are lower in after-market hours amid a securities class action lawsuit regarding its Copilot products and concerns over capital expenditures ahead of earnings.

2026-07-22 23:36; UTC

Social Media
News

Rocket Lab shares are lower in after-market hours, reflecting broader sector trends. The company will release second-quarter 2026 results on August 10, 2026.

2026-07-22 23:31; UTC

Social Media
News

Leslie's Inc shares declined in after-hours trading amid reports of a potential Chapter 11 bankruptcy, raising concerns about the company's financial stability.

2026-07-22 23:26; UTC

News

Synopsys Inc will report third-quarter results on August 26, 2026, after market close. Shares are trading higher in after-market hours.

2026-07-22 23:22; UTC

Social Media
News

Tesla Inc. shares declined in after-hours trading following a Q2 earnings miss, with adjusted EPS at $0.33 against expectations of $0.51.

2026-07-22 23:22; UTC

Social Media
News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

2026-07-22 23:16; UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

2026-07-22 23:16; UTC

News

Interactive Brokers reported second-quarter net revenue growth of 28% to $1.90 billion, driven by a 67% increase in customer margin loans.

2026-07-22 23:11; UTC

Social Media
News

Lockheed Martin announced a quarterly dividend of $3.45 per share, boosting investor sentiment. Shares are higher in after-market trading following the announcement.

2026-07-22 23:06; UTC

News

Constellation Energy Corp shares are lower in after-market trading, influenced by geopolitical tensions and concerns over potential oil supply disruptions.

2026-07-22 23:06; UTC

News

Dollar Tree shares are lower in after-market trading amid scrutiny over new price scanners and rising costs, prompting concerns about customer loyalty.

2026-07-22 23:06; UTC

News

General Motors raised its 2026 profit outlook to $14 billion to $16 billion, boosting shares higher in after-market hours following strong EBIT performance.

2026-07-22 23:02; UTC

Social Media
News

QuantumScape Corp's shares declined in after-market hours following a narrower loss and lowered capital expenditures guidance amid concerns over future cash flow.

Akcijų palyginimas

Kainos pokytis

Zai Lab Ltd ADR Prognozė

Kainos tikslas

By TipRanks

58.05% į viršų

12 mėnesių prognozė

Vidutinis 32.4 USD  58.05%

Aukščiausias 44 USD

Žemiausias 21.6 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zai Lab Ltd ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

3

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

134 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat